Shuyang Zhang Selected Research

Troponin I

12/2020	Swollen heart in COVID-19 patients who progress to critical illness: a perspective from echo-cardiologists.
1/2020	Clinical Characteristics, Treatment, and Outcomes in Patients with Idiopathic Inflammatory Myopathy Concomitant with Heart Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuyang Zhang Research Topics

Disease

21	COVID-19 12/2022 - 01/2020
13	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 04/2013
8	Thrombosis (Thrombus) 01/2022 - 08/2005
8	Atherosclerosis 01/2021 - 07/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2020
6	Acute Coronary Syndrome 11/2021 - 12/2012
6	Inflammation (Inflammations) 02/2021 - 01/2005
6	Hypertension (High Blood Pressure) 03/2017 - 01/2005
5	Infections 01/2021 - 01/2005
5	Myocardial Infarction 06/2019 - 01/2005
4	Hemorrhage 01/2022 - 01/2014
4	Heart Failure 01/2022 - 10/2020
4	Amyloidosis 09/2021 - 03/2020
4	Critical Illness (Critically Ill) 12/2020 - 01/2020
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2020 - 07/2013
4	Cardiomyopathies (Cardiomyopathy) 03/2020 - 01/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 01/2005
3	Disease Progression 12/2022 - 05/2014
3	Neoplasms (Cancer) 01/2022 - 04/2020
3	Dyslipidemias (Dyslipidemia) 11/2021 - 01/2011
3	Obesity 10/2021 - 01/2005
3	ST Elevation Myocardial Infarction 02/2021 - 04/2015
3	Hypercholesterolemia 01/2021 - 12/2015
3	Rare Diseases (Rare Disease) 01/2021 - 01/2018
3	Ischemic Stroke 01/2020 - 01/2018
3	Pathologic Dilatation (Ectasia) 01/2018 - 01/2016
2	Virus Diseases (Viral Diseases) 12/2022 - 01/2020
2	Hemophilia A (Haemophilia) 05/2022 - 01/2021
2	Fibrosis (Cirrhosis) 01/2022 - 01/2020
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2021
2	Acromegaly 01/2021 - 01/2020
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2021
2	Stroke (Strokes) 01/2020 - 08/2005
2	Diabetes Mellitus 04/2015 - 12/2012
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Xanthomatosis (Xanthoma) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Proteinuria 01/2022
1	Pseudohypoaldosteronism 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022
1	Localized Scleroderma (Morphea) 01/2022

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2014
5	LipidsIBA 01/2022 - 09/2014
5	oxidized low density lipoproteinIBA 01/2022 - 09/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
4	LigandsIBA 01/2022 - 09/2014
4	CytokinesIBA 01/2022 - 10/2020
4	LDL CholesterolIBA 01/2022 - 09/2014
4	AntibodiesIBA 01/2021 - 01/2005
4	C-Reactive ProteinIBA 01/2019 - 01/2005
3	Angiotensin IIIBA 01/2022 - 05/2014
3	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2015
3	ChemokinesIBA 01/2022 - 02/2015
3	Prealbumin (Transthyretin)IBA 09/2021 - 11/2019
3	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 12/2012
3	CholesterolIBA 01/2021 - 01/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 07/2013
3	Antiphospholipid AntibodiesIBA 12/2020 - 01/2020
3	Peptide Hydrolases (Proteases)FDA Link 04/2016 - 01/2016
2	Heme (Haem)IBA 05/2022 - 01/2021
2	ProteomeIBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	GlucocorticoidsIBA 01/2022 - 01/2020
2	Chemokine CCL17IBA 01/2022 - 02/2015
2	Glycoproteins (Glycoprotein)IBA 10/2021 - 12/2020
2	Viral RNAIBA 02/2021 - 01/2020
2	Technetium Tc 99m PyrophosphateIBA 01/2021 - 03/2020
2	CeramidesIBA 01/2021 - 01/2019
2	Peptides (Polypeptides)IBA 01/2021 - 05/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 04/2015
2	Troponin IIBA 12/2020 - 01/2020
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2020 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2015
2	ORALIT (ORS)IBA 01/2020 - 05/2013
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2019 - 01/2014
2	omega-Chloroacetophenone (Mace)IBA 06/2019 - 01/2014
2	Warfarin (Coumadin)FDA LinkGeneric 12/2016 - 12/2015
2	AnticoagulantsIBA 12/2016 - 01/2014
2	SootIBA 01/2016 - 04/2014
2	CC ChemokinesIBA 02/2015 - 09/2014
1	Viral AntigensIBA 12/2022
1	Angiogenesis InhibitorsIBA 05/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	gallium Ga 68 dotatateIBA 01/2022
1	68Ga-FAPIIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022

Therapy/Procedure

20	Therapeutics 12/2022 - 01/2014
8	Percutaneous Coronary Intervention 10/2022 - 01/2014
4	Drug Therapy (Chemotherapy) 05/2022 - 01/2020
3	Immunotherapy 05/2022 - 03/2021
3	Drug-Eluting Stents 06/2019 - 01/2013
2	Personal Protective Equipment 02/2021 - 10/2020
2	Aftercare (After-Treatment) 01/2021 - 01/2011
2	Mechanical Ventilators (Ventilator) 03/2020 - 01/2018
2	Semiconductors 01/2018 - 06/2013
2	Stents 01/2017 - 08/2005